Nuclear Medicine
New Nuclear Medicine Research from University Hospital Outlined
Published in Blood Weekly, February 10th, 2011
2011 FEB 10 -- According to a study from Lausanne, Switzerland, "This study aimed at identifying clinical factors for predicting hematologic toxicity after radioimmunotherapy with Y-90-ibritumomab tiuxetan or I-131-tositumomab in clinical practice. Hematologic data were available from 14 non-Hodgkin lymphoma patients treated with Y-90-ibritumomab tiuxetan and 18 who received I-131-tositumomab."
"The percentage baseline at nadir and 4 wk post nadir and the time to nadir were selected as the toxicity indicators for both platelets and neutrophils. Multiple linear regression analysis was performed to identify significant predictors (P < 0.05) of each...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2011-02-10)
More Articles from Blood Weekly
- Blood Transfusion
Data on Blood Transfusion Published by V. Witt and Colleagues - Blood Purification
Reports Summarize Blood Purification Research from M. Ishihara and Co-Authors - Blood Purification
Research on Blood Purification Detailed by F. Tarrass and Co-Authors - Blood Transfusion
Researchers from St. James University Report Recent Findings in Blood Transfusion - Blood Transfusion
Studies Conducted at S. Bahadur et al on Blood Transfusion Recently Published - Tissue Engineering
Case Western Reserve University, Department of Biomedical Engineering Details Research in Tissue Engineering - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
